Login

Dr Stuart Quin, CEO of Medica Group PLC 00:00:00

Share On Facebook Share On Twitter

Dr Stuart Quin, CEO of Medica Group PLC, discusses the Group's first-half performance

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Venture capital firm on a mission to diversify the face of wealth|Diana Murakhovskaya,Co-Founder and General Partner,The Artemis Fund
00:10:00
Navigating Inheritance Taxes: What Beneficiaries Need to Know | Michelle Smalenberger, CEO, Financial Design Studio.
00:10:00
What methods can we employ to responsibly provide food for an expanding global populace|Johan Westman, CEO,AAK
00:10:00
Anastasia Amoroso from iCapital joins 'Closing Bell' to discuss identifying market upside in specific stocks and shares her market outlook.
00:10:00
Global Infrastructure Investment Company Shares Strategy and Market Insights | Jason Boyes, CEO, Infratil Ltd.
00:10:00
Navigating Special Situations: Insights from Kotak Special Opportunities Fund | Shibani Kurian - Senior Fund Manager, Kotak Mutual Fund
00:00:00
Lots to look forward to' as ReNeuron gets go-ahead for phase IIb stroke trial - Michael Hunt, Chief Financial Officer, ReNeuron Group
00:10:00
The Future of Climate Finance: Insights from the Green Climate Fund and Industry Leaders | Howard Bamsey - Mike Eckhart - Melanie Nakagawa - Bruce Usher
00:10:00
Nusantara Resources: Unveiling the Potential of the Awak Mas Gold Project
00:10:00
Kiliman & Baird: Personalized Investment and Client Care Since 1966
00:10:00
Maximizing Returns: Strategies for Growth Capital in Private Credit Markets | Jean-Pierre L. Conte, Chairman ,  Genstar Capital.
00:10:00
ABL Group is a leading energy and marine consultancy, known for its market value in offshore consulting, recently discussed by Marhelm in an interview with Archer CEO Dag.|Mr. Reuben Segal has been the Chief Executive Officer of the company since 2022. Pr

© 2026 Nehu